Loading stock…

XPO, Inc. (XPO) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

XPOXPO

Revenue FY25$8.2B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+11%6

Revenue, next 3Y, CAGR+7%6

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+109%10

EPS growth, FY27E+18%8

EPS growth, FY28E+16%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 2%/yr over the last 3 years and is set to grow 7%/yr from here.

Earnings are set to grow faster than sales (EPS about 18%/yr vs revenue 7%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, a little ahead of the market.6/10

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE59 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-5%5

3-month return-12%3

YTD return+33%9

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return+31%8

3-year return+134%8

5-year return+288%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +134% over three years and +288% over five, ahead of 80% of the market.

It's up 31% over the past year, but 22% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+33%).

WATCH

Returns sit at the market level over the past month (-5%).

WEAKNESSES

The stock is underperforming over three months (-12%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on XPO. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

XPOXPO

Revenue FY25$8.2B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+11%6

Revenue, next 3Y, CAGR+7%6

Revenue, next 5Y, CAGR+7%6

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+109%10

EPS growth, FY27E+18%8

EPS growth, FY28E+16%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 2%/yr over the last 3 years and is set to grow 7%/yr from here.

Earnings are set to grow faster than sales (EPS about 18%/yr vs revenue 7%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, a little ahead of the market.6/10

Over five years revenue is set to grow 7%/yr, ahead of 50% of companies worldwide.6/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE59 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-5%5

3-month return-12%3

YTD return+33%9

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return+31%8

3-year return+134%8

5-year return+288%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +134% over three years and +288% over five, ahead of 80% of the market.

It's up 31% over the past year, but 22% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+33%).

WATCH

Returns sit at the market level over the past month (-5%).

WEAKNESSES

The stock is underperforming over three months (-12%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on XPO. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

XPO, Inc.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on XPO. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on XPO. Get the full investment case.

Premium